Your browser doesn't support javascript.
loading
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014.
Dutcher, Janice P; Schwartzentruber, Douglas J; Kaufman, Howard L; Agarwala, Sanjiv S; Tarhini, Ahmad A; Lowder, James N; Atkins, Michael B.
Afiliación
  • Dutcher JP; Associate Director, Cancer Research Foundation, Chappaqua, NY, USA. jpd4401@aol.com.
  • Schwartzentruber DJ; Associate Director of Clinical Operations, Professor of Surgery, IU Simon Cancer Center, 550 N University Blvd, Indianapolis, 46202, IN, USA.
  • Kaufman HL; Chief Surgical Officer and Associate Director for Clinical Science, Professor of Surgery, Rutgers Cancer Center Institute of New Jersey, 195 Little Albany Street, Room 2007, New Brunswick, 08901, NJ, USA.
  • Agarwala SS; Chief of Medical Oncology and Professor of Medicine, St. Luke's Cancer Center, Bethlehem, 18015, PA, USA.
  • Tarhini AA; Associate Professor of Medicine and Translational Science, University of Pittsburgh Cancer Institute, Suite 555, 5150 Centre Ave, Pittsburgh, 15232, PA, USA.
  • Lowder JN; Senior Medical Director, Prometheus Laboratories Inc, 9410 Carroll Park Drive, San Diego, 92121, CA, USA.
  • Atkins MB; Deputy Director, Professor of Medicine, Georgetown-Lombardi Comprehensive Cancer Center, 3970 Reservoir Rd NW, NRB-E501, Washington, 20057, DC, USA.
J Immunother Cancer ; 2(1): 26, 2014 Sep 16.
Article en En | MEDLINE | ID: mdl-31546315
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Immunother Cancer Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Immunother Cancer Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos